This study examined how peripheral conventional type 1 dendritic cells (cDC1s) prime CD8+ T cells to infiltrate the brain and drive tau-mediated neurodegeneration, using tauopathy mouse models lacking cDC1s or antigen cross-presentation.
Tauopathy mice deficient in cDC1s or antigen cross-presentation were protected from neurodegeneration, showing reduced brain CD8+ T cell infiltration, decreased glial activation, and limited CD8+ T cell clonal expansion — consistent with impaired peripheral priming. Brain-derived antigens were detected in secondary lymphoid tissues, pointing to those as the site of T cell activation.
Findings are based on mouse tauopathy models, which may not fully replicate human Alzheimer's disease or primary tauopathies. The study does not identify the specific tau-derived antigens presented by cDC1s. Causal directionality in human disease remains to be established.
The cDC1-dependent peripheral priming pathway is a potential therapeutic target to limit CD8+ T cell-driven neurodegeneration in tauopathies. Strategies that disrupt dendritic cell cross-presentation or CD8+ T cell trafficking could be explored in Alzheimer's disease and related conditions.